跳至主要内容
临床试验/NCT03717519
NCT03717519已完成不适用

Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases: a Retrospective Single-center Cohort Study

Azienda Ospedaliera Universitaria Integrata Verona1 个研究点 分布在 1 个国家目标入组 196 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
196
试验地点
1
主要终点
Overall survival

研究概览

简要总结

Colorectal cancer (CRC) is the third most common malignancy worldwide and is often metastatic at diagnosis. Despite progresses in surgical techniques and the introduction of novel chemotherapy regimens, many patients still suffer from a poor prognosis. It is therefore of utmost importance to identify prognostic markers that may improve selection of patients.

In recent years several studies demonstrated that preoperative blood tests as platelet count or neuthophil-to-lymphocyte ratio could be prognostic factors in CRC as well as other malignancies. The aim of this study was to evaluate the role of preoperative platelet count (PC) in patients with synchronous colorectal liver metastases.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Colorectal cancer with synchronous liver metastases
  • Possibility to retrieve pre-operative platelet count
  • Age of 18 years or older
  • Availabilty of clinical-pathological data
  • Minimum follow up of 12 months

排除标准

  • 未提供

结局指标

主要结局

Overall survival

时间窗: 5 years

correlation between high PC and overall survival

次要结局

  • Clinic-pathological variables(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Corrado Pedrazzani

Principal Investigator

Azienda Ospedaliera Universitaria Integrata Verona

研究点 (1)

Loading locations...

相似试验